Andrew Peranick

Andrew Peranick, CFA has a comprehensive work experience in corporate and financial strategy, starting from their roles as a Research Analyst at Deutsche Bank Securities in 2003 to their recent position as the Director of Corporate and Financial Strategy at Adiso Therapeutics since 2022. Andrew has also held significant roles at various companies such as Contrarian Capital Management, Radcliffe Capital Management, and Bastogne Capital Management, where they co-founded a hedge fund and successfully grew assets under management. Andrew'sexperience includes extensive analysis of distressed and special situation investment opportunities, trading, and managing proprietary trading books.

Andrew Peranick, CFA obtained their degree in Finance from Fairfield University from 1999 to 2003.